1. Home
  2. WRB vs RMD Comparison

WRB vs RMD Comparison

Compare WRB & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo W.R. Berkley Corporation

WRB

W.R. Berkley Corporation

HOLD

Current Price

$66.26

Market Cap

25.7B

Sector

Finance

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$190.78

Market Cap

29.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRB
RMD
Founded
1967
1989
Country
United States
United States
Employees
8804
10600
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.7B
29.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WRB
RMD
Price
$66.26
$190.78
Analyst Decision
Hold
Buy
Analyst Count
16
10
Target Price
$68.86
$292.56
AVG Volume (30 Days)
1.8M
1.4M
Earning Date
04-21-2026
04-30-2026
Dividend Yield
2.78%
1.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.18
$10.60
Revenue Next Year
$4.95
$7.41
P/E Ratio
$15.91
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$62.87
$180.27
52 Week High
$78.96
$293.81

Technical Indicators

Market Signals
Indicator
WRB
RMD
Relative Strength Index (RSI) 50.52 35.35
Support Level $64.85 N/A
Resistance Level $68.91 $260.21
Average True Range (ATR) 1.38 5.63
MACD -0.12 -1.25
Stochastic Oscillator 54.46 33.57

Price Performance

Historical Comparison
WRB
RMD

About WRB W.R. Berkley Corporation

W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: